Literature DB >> 32249371

Polysomnographic characteristics of severe obstructive sleep apnea vary significantly between hypertensive and normotensive patients of both genders.

T Leppänen1,2, A Kulkas3,4, J Töyräs3,5,6, S Myllymaa3,5, N Gadoth7,8, A Oksenberg7.   

Abstract

PURPOSE: Hypertension is a common finding in patients with obstructive sleep apnea (OSA), but it has remained unclear whether or not the amount of disturbed breathing and characteristics of individual respiratory events differ between hypertensive and normotensive patients with severe OSA.
METHODS: Full polysomnographic recordings of 323 men and 89 women with severe OSA were analyzed. Differences in the duration of individual respiratory events, total apnea and hypopnea times, and the percentage of disturbed breathing from total sleep time (AHT%) were compared between normotensive and hypertensive patients separately by genders. Furthermore, differences in the respiratory event characteristics were assessed between three AHT% groups (AHT% ≤ 30%, 30% < AHT% ≤ 45%, and AHT% > 45%).
RESULTS: Hypertensive women had lower percentage apnea time (15.2% vs. 18.2%, p = 0.003) and AHT% (33.5% vs. 36.5%, p = 0.021) when compared with normotensive women. However, these differences were not observed between hypertensive and normotensive men. Percentage hypopnea time was higher in hypertensive men (13.5% vs. 11.2%, p = 0.043) but not in women (15.2% vs. 12.2%, p = 0.130) compared with their normotensive counterparts. The variation in AHI explained 60.5% (ρ = 0.778) and 65.0% (ρ = 0.806) of the variation in AHT% in normotensive and hypertensive patients, respectively. However, when AHT% increased, the capability of AHI to explain the variation in AHT% declined.
CONCLUSIONS: There is a major inter- and intra-gender variation in percentage apnea and hypopnea times between hypertensive and normotensive patients with severe OSA. OSA is an important risk factor for hypertension and thus, early detection and phenotyping of OSA would allow timely treatment of patients with the highest risk of hypertension.

Entities:  

Keywords:  Apnea duration; Gender; Hypertension; Hypopnea duration; OSA; Phenotype

Year:  2020        PMID: 32249371      PMCID: PMC7987592          DOI: 10.1007/s11325-020-02047-8

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  27 in total

1.  Revise Respiratory Event Criteria or Revise Severity Thresholds for Sleep Apnea Definition?

Authors:  Thomas Penzel; Christoph Schöbel; Ingo Fietze
Journal:  J Clin Sleep Med       Date:  2015-12-15       Impact factor: 4.062

2.  Increase in Body Mass Index Decreases Duration of Apneas and Hypopneas in Obstructive Sleep Apnea.

Authors:  Timo Leppänen; Antti Kulkas; Esa Mervaala; Juha Töyräs
Journal:  Respir Care       Date:  2019-01       Impact factor: 2.258

3.  The economic cost of inadequate sleep.

Authors:  David Hillman; Scott Mitchell; Jared Streatfeild; Chloe Burns; Dorothy Bruck; Lynne Pezzullo
Journal:  Sleep       Date:  2018-08-01       Impact factor: 5.849

Review 4.  Obstructive sleep apnea and risk of stroke: a meta-analysis of prospective studies.

Authors:  Min Li; Wen-Shang Hou; Xiao-Wei Zhang; Zhen-Yu Tang
Journal:  Int J Cardiol       Date:  2014-01-10       Impact factor: 4.164

Review 5.  Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches.

Authors:  Andrey V Zinchuk; Mark J Gentry; John Concato; Henry K Yaggi
Journal:  Sleep Med Rev       Date:  2016-10-12       Impact factor: 11.609

Review 6.  Heart failure and sleep disorders.

Authors:  Gianfranco Parati; Carolina Lombardi; Francesco Castagna; Paola Mattaliano; Pasquale Perrone Filardi; Piergiuseppe Agostoni
Journal:  Nat Rev Cardiol       Date:  2016-05-12       Impact factor: 32.419

7.  Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine.

Authors:  Richard B Berry; Rohit Budhiraja; Daniel J Gottlieb; David Gozal; Conrad Iber; Vishesh K Kapur; Carole L Marcus; Reena Mehra; Sairam Parthasarathy; Stuart F Quan; Susan Redline; Kingman P Strohl; Sally L Davidson Ward; Michelle M Tangredi
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

8.  Severe obstructive sleep apnea: sleepy versus nonsleepy patients.

Authors:  Arie Oksenberg; Elena Arons; Khitam Nasser; Ophir Shneor; Henryk Radwan; Donald S Silverberg
Journal:  Laryngoscope       Date:  2010-03       Impact factor: 3.325

9.  Novel parameters for evaluating severity of sleep disordered breathing and for supporting diagnosis of sleep apnea-hypopnea syndrome.

Authors:  A Kulkas; P Tiihonen; K Eskola; P Julkunen; E Mervaala; J Töyräs
Journal:  J Med Eng Technol       Date:  2013-02

Review 10.  Obstructive sleep apnea and cardiovascular disease: a perspective and future directions.

Authors:  Allan I Pack; Thorarinn Gislason
Journal:  Prog Cardiovasc Dis       Date:  2009 Mar-Apr       Impact factor: 8.194

View more
  1 in total

1.  Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy.

Authors:  Yuanyuan Fan; Nazeer Hussain Khan; Muhammad Farhan Ali Khan; M D Faysal Ahammad; Tayyaba Zulfiqar; Razia Virk; Enshe Jiang
Journal:  Cancer Manag Res       Date:  2022-04-01       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.